![Priya Singhal](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Priya Singhal
Företagsledare/Principal på
BIOGEN INC.
Förmögenhet: 2 M $ per 2026-05-31
Profil
Priya Singhal is currently Executive Vice President & Head-Development at Biogen, Inc. since 2021.
Formerly, Dr. Singhal was Head-Medical Affairs & Vice President at Vertex Pharmaceuticals, Inc. from 2008 to 2012, VP-Clinical Trials Benefit Risk Management at Biogen, Inc. from 2012 to 2018, and Head-Research & Development at Zafgen, Inc. from 2019 to 2020.
Education includes a doctorate from the University of Mumbai and graduate studies at Harvard T.H.
Chan School of Public Health.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
BIOGEN INC. 0,01 % | 2026-04-21 | 8 043 ( 0,01 % ) | 2 M $ | 2026-05-31 |
Aktiva positioner av Priya Singhal
| Företag | Position | Start |
|---|---|---|
| BIOGEN INC. | Företagsledare/Principal | - |
Tidigare kända positioner av Priya Singhal
| Företag | Position | Slut |
|---|---|---|
| LARIMAR THERAPEUTICS, INC. | Teknisk/Vetenskaplig/F&U Direktör | 2020-01-01 |
| BIOGEN INC. | Företagsledare/Principal | 2018-01-01 |
| VERTEX PHARMACEUTICALS INCORPORATED | Teknisk/Vetenskaplig/F&U Direktör | 2012-01-01 |
Priya Singhals utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
77
Första gradens relationer
5
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Zafgen, Inc.
 Zafgen, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company | Health Technology |
University of Mumbai
 University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard T.H. Chan School of Public Health
 Harvard T.H. Chan School of Public Health Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
